Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets
Haley L. Dugan, Christopher T. Stamper, Lei Li, Siriruk Changrob, Nicholas Asby, Peter Halfmann, Nai-Ying Zheng, Min Huang, Dustin G. Shaw, Mari Cobb, Steven A. Erickson, Jenna J. Guthmiller, Olivia Stovicek, Jiaolong Wang, Emma S. Winkler, Maria Lucia L. Madariaga, Kumaran Shanmugarajah, Maud O. Jansen, Fatima Amanat, Isabelle Stewart, Henry A. Utset, Jun Huang, Christopher A. Nelson, Ya-Nan Dai, Paige D. Hall, R. Jedrzejczak, A. Joachimiak, Florian Krammer, Michael Diamond, Daved H. Fremont, Yoshihiro Kawaoka, Patrick C. Wilson
Topics & Concepts
BiologyImmunodominanceVirologyAntibodyAntigenMemory B cellNeutralizing antibodyMonoclonal antibodyImmunologyB cellEpitopeSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesT-cell and B-cell Immunology